Ventilator-Associated Pneumonia (VAP)
Objectives
- To study the etiology and pathogenesis, diagnosis, prevention and treatment of Ventilator-Associated Pneumonia (VAP)
- To identify biomarkers for diagnosis and outcome of VAP
- To study the formation of biofilm in intubated and mechanically ventilated patients
Projects in Progress
- Microbiological and electron microscope study of biofilm in endotracheal tubes
- Efficacy of corticosteroids in patients with VAP
- Role of interleukins in diagnosis and outcome of VAP
- Pneumonia in the intensive care unit (ICU), associated and not associated with mechanical ventilation
Milestones Achieved
- The half-sitting position in bed in ventilated patients reduces the incidence of VAP
- Procalcitonin (PCT) is an effective marker for confirming diagnosis of VAP
- Automatic control of tracheal tube pressure does not affect the incidence of VAP
Future Challenges
- Identification of new VAP biomarkers
- Evaluation of new VAP therapies
- Evaluation of measures to prevent the formation of biofilm in endotracheal tubes
- Clinical monitoring of patients with VAP in order to adapt empirical treatment to the changes in the etiologic agents
Publications
Sequential measurements of procalcitonin in diagnosing ventilator-associated pneumonia
Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sauquillo JM, Menendez R, Asenjo MA, Torres A.
Eur Respir J 2008;31:356-362
Automatic control of tracheal tube cuff pressure in ventilated patients in semirecumbent position. A randomized trial
Valencia M, Ferrer M, Farre R, Navajas D, Badia JR, Nicolas JM, Torres A
Crit Care Med 2007: 35: 1543-1549. (text a continuació en idiomes!)
Supine body position is a risk factor of nosocomial pneumonia in mechanically ventilated patients. A randomised clinical trial
Drakulovic MB, Torres A, Bauer TT, Nicolás JM, Nogué S, Ferrer M
The Lancet 1999; 354: 1851-1858
Predictors of prolonged weaning and survival during ventilator weaning in a respiratory ICU
Sellares J, Ferrer M, Cano E, Loureiro H, Valencia M, Torres A
Intensive Care Med. 2011 Mar 4. [Epub ahead of print]
Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients
Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo LM, Zavala E, Welte T, Torres A
Am J Respir Crit Care Med. 2010 Dec 15;182(12):1533-9.
Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial
Ferrer M, Sellarés J, Valencia M, Carrillo A, Gonzalez G, Badia JR, Nicolas JM, Torres A
Lancet. 2009 Sep 26;374(9695):1082-8.
Respiratory impedance during weaning from mechanical ventilation in a mixed population of critically ill patients.
Sellares J, Acerbi I, Loureiro H, Dellaca RL, Ferrer M, Torres A, Navajas D, Farre R.
Br J Anaesth. 2009 Dec;103(6):828-32. Epub 2009 Nov 3.
Validation of the American Thoracic Society–Infectious Diseases Society of America Guidelines for Hospital-Acquired Pneumonia in the Intensive Care Unit.
Ferrer M, Liapikou A, Valencia M, Esperatti M, Theessen A, Martinez JA, Mensa J, Torres A.
Clin Infect Dis 2010; 50: 945–952.
Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs
Martinez-Olondris P, Rigol M, Soy D, Guerrero L, Agusti C, Quera MA, Li Bassi G, Esperatti M, Luque N, Liapikou M, Filella X, Marco F, de la Bellacasa JP, Torres A.
Crit Care Med. 2011 Sep 15.
Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia
Torres A, Ferrer M, Badia JR.
Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S48-53
Update in community-acquired and nosocomial pneumonia 2009
Torres A, Rello J
Am J Respir Crit Care Med. 2010 Apr 15;181(8):782-7.
Lines list
- Alpha-1-antitrypsin deficiency (AATD)
- Animal Model
- Bronchiectasis non associated to Cystic Fibrosis (BQ-noFQ), Cystic Fibrosis (CF) and immune deficiencies
- Community-Acquired Pneumonia (CAP)
- Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
- Networks, European Projects and Collaborations
- Noninvasive Ventilation (NIV)
- Pulmonary complications in immunocompromised (IC) patients
- Ventilator-Associated Pneumonia (VAP)



